Forier Cynthia, Boschetti Egisto, Ouhammouch Mohamed, Cibiel Agnès, Ducongé Frédéric, Nogré Michel, Tellier Michel, Bataille Damien, Bihoreau Nicolas, Santambien Patrick, Chtourou Sami, Perret Gérald
LFB Biotechnologies, Les Ulis, France.
Bioconsultant, JAM Conseil, Neuilly, France.
J Chromatogr A. 2017 Mar 17;1489:39-50. doi: 10.1016/j.chroma.2017.01.031. Epub 2017 Jan 17.
Nucleic acid aptamers are promising ligands for analytical and preparative-scale affinity chromatography applications. However, a full industrial exploitation requires that aptamer-grafted chromatography media provide a number of high technical standards that remained largely untested. Ideally, they should exhibit relatively high binding capacity associated to a very high degree of specificity. In addition, they must be highly resistant to harsh cleaning/sanitization conditions, as well as to prolonged and repeated exposure to biological environment. Here, we present practical examples of aptamer affinity chromatography for the purification of three human therapeutic proteins from various sources: Factor VII, Factor H and Factor IX. In a single chromatographic step, three DNA aptamer ligands enabled the efficient purification of their target protein, with an unprecedented degree of selectivity (from 0.5% to 98% of purity in one step). Furthermore, these aptamers demonstrated a high stability under harsh sanitization conditions (100h soaking in 1M NaOH). These results pave the way toward a wider adoption of aptamer-based affinity ligands in the industrial-scale purification of not only plasma-derived proteins but also of any other protein in general.
核酸适体是用于分析和制备规模亲和色谱应用的有前景的配体。然而,要实现全面的工业应用,需要适体接枝的色谱介质满足一系列尚未得到充分验证的高技术标准。理想情况下,它们应具有相对较高的结合能力以及高度的特异性。此外,它们必须对苛刻的清洗/消毒条件具有高度抗性,并且能够耐受长时间和反复暴露于生物环境。在此,我们展示了适体亲和色谱用于从多种来源纯化三种人类治疗性蛋白质的实际例子:凝血因子VII、补体因子H和凝血因子IX。在单一色谱步骤中,三种DNA适体配体能够高效纯化其靶蛋白,具有前所未有的选择性(一步纯化后纯度从0.5%提高到98%)。此外,这些适体在苛刻的消毒条件下(在1M NaOH中浸泡100小时)表现出高稳定性。这些结果为在工业规模上更广泛地采用基于适体的亲和配体铺平了道路,不仅可用于血浆衍生蛋白的纯化,也可用于一般任何其他蛋白质的纯化。